Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2016 Jul 25.
Published in final edited form as: Cerebrovasc Dis. 2015 Jul 25;40(0):136–143. doi: 10.1159/000434761

Cigarette smoking and carotid plaque echodensity in the Northern Manhattan Study

Dixon Yang a, Sunil Iyer a, Hannah Gardener a, David Della-Morte a,b, Milita Crisby c, Chuanhui Dong a, Ken Cheung d, Consuelo Mora-McLaughlin d, Clinton B Wright a, Mitchell S Elkind d, Ralph L Sacco a, Tatjana Rundek a
PMCID: PMC4567425  NIHMSID: NIHMS699788  PMID: 26227885

Abstract

Background

We sought to determine the association between cigarette smoking and carotid plaque ultrasound morphology in a multi-ethnic cohort.

Methods

We analyzed 1,743 stroke-free participants (mean age, 65.5±8.9 years; 60% women; 18% white, 63% Hispanic, 19% black; 14% current and 38% former smokers, 48% never smoked) from the Northern Manhattan Study using an ultrasound index of plaque echodensity, the Gray-Scale Median (GSM). Echolucent plaque (low GSM) represents soft plaque and echodense (high GSM) more calcified plaque. The mean GSM weighted by plaque area for each plaque was calculated for those with multiple plaques. Quintiles of GSM were compared to no plaque. Multinomial logistic regression models were used to assess associations of cigarette smoking with GSM, adjusting for demographics and vascular risk factors.

Results

Among subjects with carotid plaque (58%), the mean GSM scores for quintiles 1 to 5 were 48, 72, 90, 105, and 128, respectively. Current smokers had over a 2-fold increased risk of having GSM in quintile 1 (Odds Ratio [OR]=2.17; 95% Confidence Interval [CI], 1.34–3.52), quintile 2 (OR=2.33; CI, 1.42–3.83), quintile 4 (OR=2.05; CI, 1.19–3.51), and quintile 5 (OR=2.13; CI, 1.27–3.56) but not in quintile 3 (OR=1.18; CI, 0.67–2.10) as compared to never smokers in fully adjusted models. Former smokers had increased risk in quintile 2 (OR=1.46; CI, 1.00–2.12), quintile 3 (OR=1.56; CI, 1.09–2.24), quintile 4 (OR=1.66; CI, 1.13–2.42), and quintile 5 (OR=1.73; CI, 1.19–2.51), but not in quintile 1 (OR=1.05; CI, 0.72–1.55).

Conclusions

A non-linear, Vshaped like relationship between current cigarette smoking and plaque echodensity was observed. Former smokers were at highest risk for plaques in high GSM quintiles. Thus, current smokers were more likely to have either soft or calcified plaques and former smokers were at greater risk of only echodense plaques when compared against never smokers. Further research is needed to determine if plaque morphology mediates an association between smoking and clinical vascular events.

Keywords: smoking, carotid plaque morphology, carotid ultrasound, gray-scale median

Introduction

Cigarette smoking is a significant risk factor for atherosclerotic vascular disease [1]. Studies have linked current cigarette smoking to increased carotid intima-media thickness (IMT) [2], endothelial dysfunction [3], reduced flow-mediated dilation, and carotid plaque [1], ultimately leading to an increased risk of ischemic stroke [4,5]. Moreover, the cumulative smoking exposure in current smokers is a significant risk factor for carotid atherosclerosis, while duration of smoking cessation in former smokers is inversely associated with carotid atherosclerosis [6]. However, little has been reported on the effect of smoking on carotid plaque morphology. Plaque pathogenesis arises from complex plaque morphology, inflammation and rupture from plaque instability [7,8]. Both stenotic plaque and plaque with minimal luminal effect are associated with an increased risk of incident ischemic cerebrovascular events [9]. Vulnerability of carotid plaque is conferred by increased risk to rupture and thromboembolism, and has been increasingly recognized as an important factor for identifying patients at risk for stroke or other vascular ischemic events [10].

Carotid ultrasonographic gray-scale median (GSM) is a computer-assisted index used to identify vulnerable plaques by their echodensity [11]. Histological observations have confirmed that low GSM values correspond to echolucent plaques with features that include high lipid content, hemorrhagic areas in a necrotic core, and a thin fibrous cap, whereas high GSM index correlate to echogenic plaques of high fibrous content and calcification [12]. In a recent meta-analysis, the presence of ultrasound-determined echolucent carotid plaque was associated with an increased risk of ipsilateral stroke across all carotid stenosis severities [13]. Studies have also linked echodense plaques to greater cerebrovascular disease risk [10,14]. Therefore, GSM score can help identify patients with vulnerable plaque at an increased risk of stroke.

Though extensive research has been conducted on the association of smoking with IMT, endothelial function, and carotid atherosclerosis, there is a lack of understanding of the relationship between smoking and carotid plaque morphology. The increased risk of vulnerable plaque formation is an additional pathological mechanism that needs further consideration because it may mediate stroke risk from cigarette smoking. Given that both echolucent and echodense plaques can increase cerebrovascular event risk [10,1316], we hypothesized current cigarette smoking is associated with increased risk of carotid plaque at all echodensity levels, but the elevation of risk would be the highest for less echogenic plaques expressed by low ultrasonographic GSM index. Therefore, we sought to determine the relationship between cigarette smoking and the risk of ultrasound-derived plaque morphology in a large, urban, multi-ethnic population from Northern Manhattan.

Methods

Study Population

Subjects were participants of the Northern Manhattan Study (NOMAS), an ongoing, prospective, population-based study of stroke incidence and vascular risk factors in an urban, multi-ethnic population [17]. Methods of NOMAS recruitment and enrollment have been previously described [18]. In brief, NOMAS enrolled 3,298 subjects who were identified by random digit dialing. Inclusion criteria were (1) age ≥39 years, (2) no prior history of stroke, and (3) had resided in the Northern Manhattan area for at least 3 months with a telephone. The study was approved by the Columbia University Medical Center and the University of Miami Institutional Review Boards. All participants gave informed consent. Using a cross-sectional design, the current study is an analysis of a subsample of NOMAS participants who received carotid ultrasound and evaluation of carotid plaque morphology by GSM.

Baseline assessment of covariates

Baseline data were collected through interviews of the community participants using standardized data collection instruments [19] and physical and neurological examinations. Race-ethnicity was based on self-identification through a series of questions modeled after the US Census. Baseline questionnaires included questions about cigarette smoking behavior, amount smoked, age at which smoking started and stopped, and current smoking. Cigarette pack-years were calculated as number of years smoked multiplied by number of cigarettes smoked per day, then divided by 20. Hypertension was defined as a systolic blood pressure (BP) ≥140 mm Hg or a diastolic BP ≥90 mm Hg or a patient’s self-report of a history of hypertension or use of antihypertensive medications. Dyslipidemia was defined as cholesterol levels >200 mg/dL or self-reported history of increased blood cholesterol levels or cholesterol-lowering medication use. Diabetes mellitus was defined as fasting blood glucose ≥126 mg/dL or the patient’s self-report of such a history or use of insulin or hypoglycemic medications. Body mass index (BMI) was calculated in kg/m2. Physical activity was defined as the frequency and duration of 14 different recreational activities during the 2-week period before the interview, as described previously [20]. Moderate alcohol use was defined as current drinking of >1 drink per month and ≤2 drinks per day.

Assessment of carotid plaque GSM

High-resolution B-mode ultrasounds (GE LogIQ 700, 9- to 13-MHz linear-array transducer) were performed by trained and certified sonographers as previously detailed [21]. Left and right carotid bifurcations and internal and common carotid arteries were examined for the presence of plaque. Plaque was defined as an area of focal wall thickening 50% greater than surrounding wall thickness confirmed by marking and comparing plaque thickness with the thickness of the surrounding wall during scanning by electronic calipers. After image normalization using linear scaling, GSM of an operator-selected blood region inside the vessel lumen was mapped to 0 and the brightest region of the adventitia was mapped to 255 using M’Ath (Imt, Inc., Paris, France) [22]. Both of these reference regions were approximately 0.4 mm2 in area and were selected on the first image of the image sequence. The reference GSM values calculated on the first frame were applied to that and all subsequent images. GSM was expressed for each plaque.

Statistical Analysis

For individuals with multiple carotid plaques, the GSM value was calculated as the mean GSM across the plaques, weighted by the plaque area for each plaque, such that the GSM for larger plaques contributed more to the calculation of the individual’s GSM value. We examined the weighted mean GSM as a categorical variable with no plaque as the reference category. Individuals with plaque were divided into quintiles of weighted mean GSM, resulting in 6 categories of the dependent variable (quintile 1, quintile 2, quintile 3, quintile 4, quintile 5 vs. no plaque). We conducted sensitivity analyses defining plaque GSM alternatively for those with multiple plaques. Specifically, the GSM in the plaque with the largest area was calculated, and those with plaque were divided into GSM quintiles and compared to no plaque as the reference category.

We used multinomial logistic regression to examine the relationship between cigarette smoking and plaque GSM categories. Cigarette smoking was modeled in two ways: continuously in pack-years, and categorically as current smoking (in the past year from baseline assessment), former smoking, and never smoking [20]. We constructed a series of two models: (1) adjusted for age, sex, and race/ethnicity and (2) additionally adjusted for high school completion and vascular risk factors (moderate alcohol use, moderate-heavy physical activity, BMI, systolic blood pressure, diastolic blood pressure, anti-hypertensive medication use, diabetes, LDL, HDL, cholesterol-lowering medication use, aspirin use). We added interaction terms to model 2 to examine potential effect modification by the demographic variables for the associations between cigarette smoking and weighted GSM. We also examined the association of the covariates of interest (demographic and vascular risk factors) with categories of cigarette smoking using chi-square tests.

Results

Among 1,746 NOMAS participants, the mean age was 65.5±8.9 years, 60% were women, 18% white, 63% Hispanic, 19% black. There were 14% current cigarette smokers, 38% former cigarette smokers, and 48% never smokers. The mean pack-years of cigarette smoking was 12.5±23.3, and the median was 0.18. Table 1 shows the distribution of demographic and vascular risk factors in the study population overall and stratified by cigarette smoking category. Current smoking was associated with younger age, male sex, black race, high school completion, moderate alcohol use, physical inactivity (none to light), lower BMI, no hypertension, and no dyslipidemia in univariate analyses. Carotid plaque was present in 58% of the study population, 21% with a single plaque and 37% with multiple plaques (Table 2). Never smokers had less plaques and smaller number of plaques than current or former smokers. Current and former smokers had very similar frequency of plague numbers. Table 3 shows the weighted mean GSM across the GSM quintiles.

Table 1.

Baseline demographics and vascular risk factors by cigarette smoking status among 1,743 individuals from the Northern Manhattan Study

Study
population
N=1746
% (n)
Never
Smoked
N=836
% (n)
Former
Smokers
N=659
% (n)
Current
Smokers
N=251
% (n)
P value
Age
  ≥65 y 51 (891) 51 (430) 55 (364) 39 (97) 0.0001
  <65 y 49 (855) 49 (406) 45 (295) 61 (154)
Sex
  Male 40 (692) 27 (229) 52 (345) 47 (118) <0.0001
  Female 60 (1054) 73 (607) 48 (314) 53 (133)
Race
  White 18 (310) 15 (129) 23 (150) 12 (31) <0.0001
  Black 19 (339) 16 (134) 19 (126) 31 (79)
  Hispanic 63 (1097) 69 (573) 58 (383) 56 (141)
High school completion
  Yes 46 (809) 41 (343) 51 (336) 52 (130) 0.0001
  No 54 (937) 59 (493) 49 (323) 48 (121)
Physical activity
  None to light 90 (1557) 91 (756) 87 (568) 94 (233) 0.01
  Moderate-heavy 10 (169) 9 (71) 13 (82) 6 (16)
Moderate alcohol use
  Yes 39 (688) 35 (294) 44 (291) 41 (103) 0.002
  No 61 (1058) 65 (542) 56 (368) 59 (148)
BMI
  <25 26 (456) 24 (199) 27 (178) 31 (79) 0.01
  25–29.9 44 (774) 43 (359) 46 (302) 45 (113)
  30+ 29 (513) 33 (278) 27 (176) 24 (59)
Hypertension
  Yes 71 (1236) 75 (628) 68 (450) 63 (158) 0.0002
  No 29 (510) 25 (208) 32 (209) 37 (93)
Diabetes
  Yes 19 (340) 19 (162) 20 (132) 18 (46) 0.88
  No 81 (1406) 81 (674) 80 (527) 82 (205)
Dyslipidemia
  Yes 64 (1124) 67 (563) 62 (409) 61 (152) 0.04
  No 36 (622) 33 (273) 38 (250) 39 (99)

Table 2.

Plaque Number Frequency by Smoking Category

Number of
plaques
Never Smoked
N=836
%
Former Smokers
N=659
%
Current Smokers
N=251
%
0 48 37 37
1 21 20 21
2 15 17 18
3 8 11 10
4 4 7 6
5 3 4 4
6 1 2 2
7 <1 <1 2
8 0 <1 1
9 0 <1 0

Table 3.

Cigarette Smoking and Plaque Morphology: Multinomial Logistic Regression Models of Cigarette Smoking Variables in Relation to Carotid Plaque GSM Quintiles

Quintile of weighted
mean GSM vs. no
plaque
N Mean Weighted
Density (±sd)
Range OR (95% CI) for former
smoking vs. never
smoking
OR (95% CI) for current
smoking vs. never
smoking

No plaque N/A N/A ref Ref

1
Model 1 200 48 (±9) 17.00–60.84 1.13 (0.78–1.62) 2.11 (1.33–3.35)
Model 2 1.05 (0.72–1.55) 2.17 (1.34–3.52)

2
Model 1 198 72 (±7) 61.00–82.58 1.41 (0.98–2.03) 2.23 (1.39–3.57)
Model 2 1.46 (1.00–2.12) 2.33 (1.42–3.83)

3
Model 1 206 90 (±4) 83.00–97.15 1.43 (1.01–2.02) 1.17 (0.70–2.01)
Model 2 1.56 (1.09–2.24) 1.18 (0.67–2.10)

4
Model 1 202 105 (±5) 97.17–113.00 1.61 (1.12–2.32) 2.12 (1.28–3.51)
Model 2 1.66 (1.13–2.42) 2.05 (1.19–3.51)

5
Model 1 202 128 (±12) 113.09–164.00 1.71 (1.19–2.32) 2.12 (1.30–3.48)
Model 2 1.73 (1.19–2.51) 2.13 (1.27–3.56)

Model 1: adjusted for age, sex, and race/ethnicity

Model 2: adjusted for age, sex, race/ethnicity, education, alcohol use, physical activity, BMI, systolic blood pressure, diastolic blood pressure, anti-hypertensive medication use, diabetes, LDL, HDL, cholesterol-lowering medication use, aspirin use

The association between cigarette smoking modeled categorically, in relation to the weighted mean GSM in the sequence of two multinomial logistic regression models is shown in Table 3. Former smokers had an increased risk of having GSM in quintiles 2–5 as compared to never smokers, and ORs appeared to increase with greater GSM. In contrast, the relationship for current smoking had an approximate V-shaped like relationship with GSM quintiles, such that current smokers had GSM more likely to be in quintiles 1, 2, 4, and 5 as compared to those who never smoked, with no increase in risk for quintile 3 (see Figure). This association was also apparent in a sensitivity analysis in which the GSM value for those with multiple plaques was calculated as that from the plaque with the largest area (data not shown). When cigarette smoking was modeled continuously in pack-years, a positive association was observed for all 5 GSM quintiles (OR, 1.01; CI, 1.00–1.02) in comparison to no plaque (data not shown). Adjustment for vascular risk factors did not substantially attenuate the associations. No interaction was observed between the demographic variables (age, sex, race/ethnicity) and the smoking variables in relation to GSM.

Figure.

Figure

Adjusted OR of Cigarette Smoking Variables (Current and Former Smokers) in Relation to Mean Weighted Carotid Plaque GSM Quintiles

Discussion

In this urban multi-ethnic population, current cigarette smokers were at an increased risk of having either predominately echolucent or echodense carotid plaque when compared to never smokers. This association simulates a non-linear, Vshaped like relationship between current cigarette smoking and plaque echodensity. Former cigarette smokers, however, had the greatest risk for echodense carotid plaque. Continuously increasing pack-years were associated with all levels of plaque echodensity. Together, these results suggest complex mechanisms that underlie the cumulative burden of smoking and benefits of smoking cessation with carotid plaque morphology.

GSM is an ultrasonographic measure of plaque echodensity that closely relates to plaque histological morphology [11,12,23,24]. Low GSM values correspond to predominately echolucent plaques that are lipid-rich with thin fibrous caps susceptible to rupture by hemodynamic shear stress and local macrophage activity [25]. Echolucent plaques have been associated with increased risk of stroke [2628]. In a recent meta-analysis of 7 studies including 7,557 subjects with a mean follow-up of 37.2 months, predominately echolucent carotid plaques were associated with an increased risk of ipsilateral stroke regardless of the stenosis severity [13]. Plaque echolucency was also shown to improve selection and risk stratification of patients undergoing carotid endarterectomy or stenting [15] and to monitor for plaque stabilization after statin treatment [29]. High GSM values represent echodense plaques with more fibrous and calcified content [12]. Echodense plaques are more likely to be found in asymptomatic patients with carotid stenosis and their association with stroke risk is less clear [30]. Thickened fibrous cap reduces proximity of the necrotic core to the vessel lumen and circulating thrombus-forming agents to provide a protective effect [28]. However, some studies have suggested differential shear stress and cap tension from micro-calcifications of a heterogeneously-structured plaque [3133]. Calcified nodules within close proximity to the luminal surface risk extruding through and rupturing the cap [10]. Additionally, calcified carotid plaque may be a marker of an active atherosclerotic process in other arterial segments or vascular beds, and therefore may be associated with increased risk of CVD [16].

Cigarette smoke exposure adversely affects all stages of plaque formation that involve endothelial dysfunction leading to increased thrombogenicity of the artery wall [1]. Stable aldehydes in cigarette smoke contribute to volatile free radical generation that impairs endothelial ability to maintain cellular levels of nitric oxide and triggers an inflammatory cascade [34]. Chronic inflammation can damage endothelial cells to expose subendothelial matrix to circulating thrombogenic factors [35]. Nicotine and smoke exposure further complicate thrombus formation by precipitating factors that may mediate plaque vulnerability. These factors include increased activity of metalloproteinases that degrade extracellular matrix of plaque caps [36], macrophage infiltration from systemic inflammation [37], immature vessel formation prone to hemorrhage [38], and increased plaque thrombogenicity from expression of tissue factor [39]. These processes may underlie our reported associations of smoking with a wide range of the plaque GSM levels, depending on the chronicity and type of the arterial wall injury and dysfunction.

We also report an increased risk of higher GSM plaque, but not lower GSM plaque, among former smokers when compared to never smokers. Previous studies reported benefits for reduction of carotid IMT and lumen diameter with smoking cessation [5,6] but have not examined the effects of smoking cessation on plaque morphology. Additionally, our data shows similar associations across all GSM levels with increasing pack-years, indicating the cumulative effects of smoking on all types of plaque morphology with their potential risk for stroke as previously demonstrated [3,6,8]. Though we cannot examine a temporal trend in our analysis, the different relationships between smoking and the plaque GSM levels highlight complex changes in plaque morphology with cumulative smoking exposure as well as with smoking cessation that warrant further investigation.

Strengths of our study include the population-based design and diverse ethnic population, which make our results more generalizable for multi-ethnic populations. Further, in busy clinical settings or large epidemiological studies, the ultrasound protocol of measuring IMT may be too time-consuming and expensive, whereas imaging of carotid plaque may be easier and more cost-effective. Our analyses determined a mean GSM value weighted by plaque area, providing a single GSM value for individuals with multiple plaques that may better represent the plaque morphology dominance in their arteries. This is both a strength and a weakness, as it involves some degree of misclassification of individuals with multiple plaques of varying echodensity. Specifically, individuals with both low and high GSM plaques may be classified in the intermediate GSM range when in reality they have both echolucent and echodense plaque and therefore may be at greatest risk due to vulnerable plaque presence. However, our results did not change in our sensitivity analyses in which the GSM value for those with multiple plaques or plaques with the largest areas were analyzed.

Perhaps the most important limitation is that the analysis is cross-sectional, limiting inferences about temporality and causality. Further limitations include our relatively small sample size for current smokers, which may have limited detection of a significant association with GSM quintile 3. However, the V-shaped relationship is still supported by the fact that the effect estimate for current smokers (vs never smokers) in relation to GSM quintile 3 was below the 95% CI range for quintiles 1, 2, 4, and 5. In addition, cigarette smoking information was assessed by self-report and therefore some degree of misclassification is possible. Residual confounding by unmeasured vascular risk factors is also a potential source of bias. We observed no effect modification by demographic variables, including age, sex, and race/ethnicity, for the association between smoking and plaque GSM. However, the power to detect significant interactions was limited. Related studies have reported varying results in effect modification by sex for the association between carotid atherosclerosis progression and smoking [40,41]. Additionally, we recently highlighted several novel genetic variants that may modify the effect of smoking on carotid plaque burden in Hispanics [42]; therefore further study is needed in other heterogeneous cohorts.

Cigarette smoking may lead to carotid plaque morphology at greatest risk for cerebrovascular events. With growing evidence of GSM being a simple and noninvasive marker of carotid plaque vulnerability, longitudinal investigations are needed on the relation between cigarette smoking and plaque echodensity to better understand how cigarette smoking influences plaque morphology, and results in vascular events.

Acknowledgments

Sources of Funding

Supported by National Institute of Neurological Disorders and Stroke grant R37 NS 29993.

Footnotes

Disclosures

None.

References

  • 1.Csordas A, Bernhard D. The biology behind the atherothrombotic effects of cigarette smoke. Nat Rev Cardiol. 2013;10:219–230. doi: 10.1038/nrcardio.2013.8. [DOI] [PubMed] [Google Scholar]
  • 2.Howard G, Wagenknecht LE, Burke GL, Diez-Roux A, Evans GW, McGovern P, et al. Cigarette smoking and progression of atherosclerosis: The Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279:119–124. doi: 10.1001/jama.279.2.119. [DOI] [PubMed] [Google Scholar]
  • 3.Celermajer DS, Sorensen KE, Georgakopoulos D, Bull C, Thomas O, Robinson J, et al. Cigarette smoking is associated with dose related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 1993;88:2149–2155. doi: 10.1161/01.cir.88.5.2149. [DOI] [PubMed] [Google Scholar]
  • 4.Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341–350. doi: 10.1056/NEJMsa1211128. [DOI] [PubMed] [Google Scholar]
  • 5.Peters SA, Huxley RR, Woodward M. Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke. 2013;44:2821–2828. doi: 10.1161/STROKEAHA.113.002342. [DOI] [PubMed] [Google Scholar]
  • 6.Kweon SS, Lee YH, Shin MH, Choi JS, Rhee JA, Choi SW, et al. Effects of cumulative smoking exposure and duration of smoking cessation on carotid artery structure. Circ J. 2012;76:2041–2047. doi: 10.1253/circj.cj-11-1353. [DOI] [PubMed] [Google Scholar]
  • 7.Gomez CR. Carotid plaque morphology and risk for stroke. Stroke. 1990;21:148–151. doi: 10.1161/01.str.21.1.148. [DOI] [PubMed] [Google Scholar]
  • 8.Glagov S, Zarins CK. What are the determinants of plaque instability and its consequences? J Vasc Surg. 1989;9:389–390. [Google Scholar]
  • 9.Rundek T, Arif H, Boden-Albala B, Elkind MS, Paik MC, Sacco RL. Carotid plaque, a subclinical precursor of vascular events: the Northern Manhattan Study. Neurology. 2008;70:1200–1207. doi: 10.1212/01.wnl.0000303969.63165.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, et al. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664–1672. doi: 10.1161/01.CIR.0000087480.94275.97. [DOI] [PubMed] [Google Scholar]
  • 11.Sztajel R, Momjian S, Momjian-Mayor I, Murith N, Djebaili K, Boissard G, et al. Stratified gray-scale median analysis and color mapping of the carotid plaque: correlation with endarterectomy specimen histology of 28 patients. Stroke. 2005;36:741–745. doi: 10.1161/01.STR.0000157599.10026.ad. [DOI] [PubMed] [Google Scholar]
  • 12.El-Barghouty NM, Levine T, Ladva S, Flanagan A, Nicolaides A. Histological verification of computerised carotid plaque characterisation. Eur J Vasc Endovasc Surg. 1999;11:414–416. doi: 10.1016/s1078-5884(96)80172-9. [DOI] [PubMed] [Google Scholar]
  • 13.Gupta A, Kesavabhotla K, Baradaran H, Kamel H, Pandya A, Giambrone AE, et al. Plaque echolucency and stroke risk in asymptomatic carotid stenosis: a systematic review and meta-analysis. Stroke. 2015;46:91–97. doi: 10.1161/STROKEAHA.114.006091. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.AbuRahma AF, Wulu JT, Jr, Crotty B. Carotid plaque ultrasound heterogeneity and severity of stenosis. Stroke. 2002;33:1772–1775. doi: 10.1161/01.str.0000019127.11189.b5. [DOI] [PubMed] [Google Scholar]
  • 15.Biasi GM, Froio A, Diethrich EB, Deleo G, Galimberti S, Mingazzini P, et al. Carotid plaque echolucency increases the risk of stroke in carotid stenting: the Imaging in Carotid Angioplasty and Risk of Stroke (ICAROS) study. Circulation. 2004;10:756–762. doi: 10.1161/01.CIR.0000138103.91187.E3. [DOI] [PubMed] [Google Scholar]
  • 16.Prabhakaran S, Singh R, Zhou X, Ramas R, Sacco RL, Rundek T. Prescence of calcified carotid plaque predicts vascular events: the Northern Manhattan Study. Atherosclerosis. 2007;195:e197–e201. doi: 10.1016/j.atherosclerosis.2007.03.044. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Sacco RL, Boden-Albaba B, Gan R, Chen X, Kargman DE, Shea S, et al. Stroke incidence among white, black, and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol. 1998;147:259–268. doi: 10.1093/oxfordjournals.aje.a009445. [DOI] [PubMed] [Google Scholar]
  • 18.White H, Boden-Albala B, Wang C, Elkind MS, Rundek T, Wright CB, et al. Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111:1327–1331. doi: 10.1161/01.CIR.0000157736.19739.D0. [DOI] [PubMed] [Google Scholar]
  • 19.Gentry EM, Kalsbeek WD, Hogelin GC, Jones JT, Gaines KL, Forman MR, et al. The behavioral risk factor surveys: II. Design, methods, and estimates from combined state data. Am J Prev Med. 1985;1:9–14. [PubMed] [Google Scholar]
  • 20.Willey JZ, Moon YP, Paik MC, Boden-Albaba B, Sacco RL, Elkind MS. Physical activity and risk of stroke in the Northern Manhattan Study. Neurology. 2009;73:1774–1779. doi: 10.1212/WNL.0b013e3181c34b58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Rundek T, Hundle R, Ratchford E, Ramas R, Sciacca R, Di Tullio MR, et al. Endothelial dysfunction is associated with carotid plaque: a cross-sectional study from the population based Northern Manhattan Study. BMC Cardiovasc Disord. 2006;17:35. doi: 10.1186/1471-2261-6-35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Kuo F, Gardener H, Dong C, Cabral D, Della-Morte D, Blanton SH, et al. Traditional cardiovascular risk factors explain the minority of variability in carotid plaque. Stroke. 2012;43:1755–1760. doi: 10.1161/STROKEAHA.112.651059. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Matsagas MI, Vasdekis SN, Gugulakis AG, Lazaris A, Foteinou M, Sechas MN. Computer-assisted ultrasonographic analysis of carotid plaques in relation to cerebrovascular symptoms, cerebral infarction, and histology. Ann Vasc Surg. 2000;14:130–137. doi: 10.1007/s100169910024. [DOI] [PubMed] [Google Scholar]
  • 24.Tegos TJ, Sohail M, Sabetai MM, Robless P, Akbar N, Pare G, et al. Echomorphologic and histopathologic characteristics of unstable carotid plaques. ANJR Am J Neuroradiol. 2000;21:1937–1944. [PMC free article] [PubMed] [Google Scholar]
  • 25.Singh AS, Atam V, Jain N, Yathish BE, Patil MR, Das L. Association of carotid plaque echogenicity with recurrence of ischemic stroke. N Am J Med Sci. 2013;5:371–376. doi: 10.4103/1947-2714.114170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Polak JF, Shemanski L, O’Leary DH, Lefkowitz D, Price TR, Savage PJ, et al. Hypoechoic plaque at US of the carotid artery: an independent risk factor for incident stroke in adults aged 65 years or older. Radiology. 1998;208:649–654. doi: 10.1148/radiology.208.3.9722841. [DOI] [PubMed] [Google Scholar]
  • 27.Grønholdt ML, Nordestgaard BG, Schroeder TV, Vorstrup S, Sillesen H. Ultrasonic echolucent carotid plaques predict future strokes. Circulation. 2001;104:68–73. doi: 10.1161/hc2601.091704. [DOI] [PubMed] [Google Scholar]
  • 28.Bassiouny H, Sakaguchi Y, Mikucki S, McKinsey J, Piano G, Gewertz B, et al. Juxtalumenal location of plaque necrosis and neoformation in symptomatic carotid stenosis. J Vasc Surg. 1997;26:585–594. doi: 10.1016/s0741-5214(97)70056-9. [DOI] [PubMed] [Google Scholar]
  • 29.Della-Morte D, Moussa I, Elkind MS, Sacco RL, Rundek T. The short-term effect of atorvastatin on carotid plaque morphology assessed by computer-assisted gray-scale densitometry: a pilot study. Neurol Res. 2011;33:991–994. doi: 10.1179/1743132811Y.0000000039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Grogan JK, Shaalan WE, Cheng H, Gewertz B, Desai T, Schwarze G, et al. B-mode ultrasonographic characterization of carotid atherosclerosis plaques in symptomatic and asymptomatic patients. J Vasc Surg. 2005;42:435–441. doi: 10.1016/j.jvs.2005.05.033. [DOI] [PubMed] [Google Scholar]
  • 31.Tegos TJ, Stavropoulos P, Sabetai MM, Khodabakhsh P, Sassano A, Nicolaides AN. Determinants of carotid plaque instability: echoicity versus heterogeneity. Eur J Vasc Endovasc Surg. 2001;22:22–30. doi: 10.1053/ejvs.2001.1412. [DOI] [PubMed] [Google Scholar]
  • 32.Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation. 1995;92:657–671. doi: 10.1161/01.cir.92.3.657. [DOI] [PubMed] [Google Scholar]
  • 33.Rambhia SH, Liang X, Xenos M, Alemu Y, Maldonado N, Kelly A, et al. Microcalcifications increase coronary vulnerable plaque rupture potential: a patient-based micro-CT fluid-structure interaction study. Ann Biomed Eng. 2012;40:1443–1454. doi: 10.1007/s10439-012-0511-x. [DOI] [PubMed] [Google Scholar]
  • 34.Barua RS, Ambrose JA, Srivastava S, DeVoe MC, Eales-Reynolds LJ. Reactive oxygen species are involved in smoking-induced dysfunction of nitric oxide biosynthesis and upregulation of endothelial nitric oxide synthase: an in vitro demonstration in human coronary artery endothelial cells. Circulation. 2003;107:2342–2347. doi: 10.1161/01.CIR.0000066691.52789.BE. [DOI] [PubMed] [Google Scholar]
  • 35.Bernhard D, Csordas A, Henderson B, Rossmann A, Kind M, Wick G. Cigarette smoke metal-catalyzed protein oxidation leads to vascular endothelial cell contraction by depolymerization of microtubules. FASEB J. 2005;19:1096–1107. doi: 10.1096/fj.04-3192com. [DOI] [PubMed] [Google Scholar]
  • 36.Carty CS, Soloway PD, Kavastha S, Bauer J, Marsan B, Ricotta JJ, et al. Nicotine and cotinine stimulate secretion of basic fibroblast growth factor and affect expression of matrix metalloproteinases in cultured human smooth muscle cells. J Vasc Surg. 1996;24:927–934. doi: 10.1016/s0741-5214(96)70038-1. [DOI] [PubMed] [Google Scholar]
  • 37.Kangavari S, Matetzky S, Shah PK, Yano J, Chyu KY, Fishbein MC, et al. Smoking increases inflammation and metalloproteinase expression in human carotid atherosclerotic plaques. J Cardiovasc Pharmacol Ther. 2004;9:291–298. doi: 10.1177/107424840400900410. [DOI] [PubMed] [Google Scholar]
  • 38.Csordas A, Kreutmaye S, Ploner C, Braun PR, Karlas A, Backovic A, et al. Cigarette smoke extract induces prolonged endoplasmic reticulum stress and autophagic cell death in human umbilical vein endothelial cells. Cardiovasc Res. 2011;92:141–148. doi: 10.1093/cvr/cvr165. [DOI] [PubMed] [Google Scholar]
  • 39.Matetzky S, Tani S, Kangavari S, Dimayuga P, Yano J, Xu H, et al. Smoking increases tissue factor expression in atherosclerotic plaques: implications for plaque thrombogenicity. Circulation. 2000;102:602–604. doi: 10.1161/01.cir.102.6.602. [DOI] [PubMed] [Google Scholar]
  • 40.Alsulaimani S, Gardener H, Elkind MS, Cheung K, Sacco RL, Rundek T. Elevated homocysteine and carotid plaque area and densitometry in the Northern Manhattan Study. Stroke. 2013;44:457–461. doi: 10.1161/STROKEAHA.112.676155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Fan AZ, Paul-Labrador M, Merz CN, Iribarren C, Dwyer JH. Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort study. BMC Cardiovasc Disord. 2006;6:42–50. doi: 10.1186/1471-2261-6-42. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Della-Morte D, Wang L, Beecham A, Blanton SH, Zhao H, Sacco RL, et al. Novel genetic variants modify the effect of smoking on carotid plaque burden in Hispanics. J Neurol Sci. 2014;344:27–31. doi: 10.1016/j.jns.2014.06.006. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES